These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28069067)
1. End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis. Lammertyn EJ; Vandermeulen E; Bellon H; Everaerts S; Verleden SE; Van Den Eynde K; Bracke KR; Brusselle GG; Goeminne PC; Verbeken EK; Vanaudenaerde BM; Dupont LJ Respir Res; 2017 Jan; 18(1):10. PubMed ID: 28069067 [TBL] [Abstract][Full Text] [Related]
2. Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis. Hubeau C; Puchelle E; Gaillard D J Allergy Clin Immunol; 2001 Oct; 108(4):524-9. PubMed ID: 11590376 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Hubeau C; Lorenzato M; Couetil JP; Hubert D; Dusser D; Puchelle E; Gaillard D Clin Exp Immunol; 2001 Apr; 124(1):69-76. PubMed ID: 11359444 [TBL] [Abstract][Full Text] [Related]
4. Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis. Bingle L; Barnes FA; Cross SS; Rassl D; Wallace WA; Campos MA; Bingle CD Respir Res; 2007 Nov; 8(1):79. PubMed ID: 17988392 [TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Regamey N; Tsartsali L; Hilliard TN; Fuchs O; Tan HL; Zhu J; Qiu YS; Alton EW; Jeffery PK; Bush A; Davies JC Thorax; 2012 Feb; 67(2):164-70. PubMed ID: 22008188 [TBL] [Abstract][Full Text] [Related]
6. Atypical activation of the unfolded protein response in cystic fibrosis airway cells contributes to p38 MAPK-mediated innate immune responses. Blohmke CJ; Mayer ML; Tang AC; Hirschfeld AF; Fjell CD; Sze MA; Falsafi R; Wang S; Hsu K; Chilvers MA; Hogg JC; Hancock RE; Turvey SE J Immunol; 2012 Dec; 189(11):5467-75. PubMed ID: 23105139 [TBL] [Abstract][Full Text] [Related]
7. Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis. Andersson CK; Andersson-Sjöland A; Mori M; Hallgren O; Pardo A; Eriksson L; Bjermer L; Löfdahl CG; Selman M; Westergren-Thorsson G; Erjefält JS Respir Res; 2011 Oct; 12(1):139. PubMed ID: 22014187 [TBL] [Abstract][Full Text] [Related]
8. Immunohistological characterization of leukocytes in the lungs of healthy mice and after bacterial intratracheal infection. Heitmann S; Tschernig T; Larbig M; Steinmetz I; Hedrich HJ; Pabst R Lab Anim; 1999 Jul; 33(3):288-94. PubMed ID: 10780849 [TBL] [Abstract][Full Text] [Related]
9. An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis. Abu-El-Haija M; Sinkora M; Meyerholz DK; Welsh MJ; McCray PB; Butler J; Uc A Pancreatology; 2011; 11(5):506-15. PubMed ID: 22057257 [TBL] [Abstract][Full Text] [Related]
10. Widespread alterations in the peripheral blood innate immune cell profile in cystic fibrosis reflect lung pathology. Mulcahy EM; Cooley MA; McGuire H; Asad S; Fazekas de St Groth B; Beggs SA; Roddam LF Immunol Cell Biol; 2019 Apr; 97(4):416-426. PubMed ID: 30633378 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulation in Cystic Fibrosis: Why and How? Giacalone VD; Dobosh BS; Gaggar A; Tirouvanziam R; Margaroli C Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397175 [TBL] [Abstract][Full Text] [Related]
12. Current Concepts and Controversies in Innate Immunity of Cystic Fibrosis Lung Disease. Ralhan A; Laval J; Lelis F; Ballbach M; Grund C; Hector A; Hartl D J Innate Immun; 2016; 8(6):531-540. PubMed ID: 27362371 [TBL] [Abstract][Full Text] [Related]
13. Immunofluorescence studies of lung tissue in cystic fibrosis. Tomashefski JF; Abramowsky CR; Chung-Park M; Wisniewska J; Bruce MC Pediatr Pathol; 1992; 12(3):313-24. PubMed ID: 1409135 [TBL] [Abstract][Full Text] [Related]
14. Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1. Ingersoll SA; Laval J; Forrest OA; Preininger M; Brown MR; Arafat D; Gibson G; Tangpricha V; Tirouvanziam R J Immunol; 2015 Jun; 194(11):5520-8. PubMed ID: 25926674 [TBL] [Abstract][Full Text] [Related]
16. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Azzawi M; Johnston PW; Majumdar S; Kay AB; Jeffery PK Am Rev Respir Dis; 1992 Jun; 145(6):1477-82. PubMed ID: 1596021 [TBL] [Abstract][Full Text] [Related]
17. Characterization of inflammatory reaction in upper airways of cystic fibrosis patients. Lesprit E; Escudier E; Roger G; Prulière V; Lenoir G; Reinert P; Coste A Histol Histopathol; 2000 Apr; 15(2):395-402. PubMed ID: 10809357 [TBL] [Abstract][Full Text] [Related]
19. The Th17 pathway in cystic fibrosis lung disease. Tan HL; Regamey N; Brown S; Bush A; Lloyd CM; Davies JC Am J Respir Crit Care Med; 2011 Jul; 184(2):252-8. PubMed ID: 21474644 [TBL] [Abstract][Full Text] [Related]
20. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. Döring G; Frank F; Boudier C; Herbert S; Fleischer B; Bellon G J Immunol; 1995 May; 154(9):4842-50. PubMed ID: 7722333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]